SRx Health Solutions (SRXH) & EMJX Just Invested in Optimi Health (OPTH) – Commercial-Stage Psychedelics Pharma Playing Psilocybin
🚀 Big move in the psychedelics sector today.
SRx Health Solutions, Inc. (NYSE: SRXH) and EMJ Crypto Technologies (EMJX) announced they are investing in Optimi Health Corp. (NASDAQ: OPTH) a commercial-stage pharmaceutical company focused on manufacturing and distributing GMP-grade psychedelic drug products for mental health therapies, including Psilocybin.
Key highlights from the press release:
• Optimi is already at the commercial stage (not just pre-clinical)
• Focused on high-quality, regulated psychedelic medicines
• Comes shortly after what appears to be a recent IPO/listing
• Part of a broader definitive merger agreement between SRx and EMJX
This feels like a notable step toward institutional/traditional finance getting more involved in the psychedelics space as the regulatory environment continues to evolve.